Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the <scp>NEURO</scp> ‐ <scp>TTRansform</scp> Clinical Trial

Thomas H. Brannagan, Markus Weiler, Márcia Waddington Cruz, Sami Khella, John L. Berk, Morie Gertz, Ahmad Masri, Mathew S. Maurer, Jonas Wixner, Jonatan Nåtman, T. Jesse Kwoh, Maksym Pola, Laura Obici

Open source

DOI: 10.1111/jns.70167
Published: 2026-09
Container: Journal of the Peripheral Nervous System
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jns.70167,
  title = {Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the
                    <scp>NEURO</scp>
                    ‐
                    <scp>TTRansform</scp>
                    Clinical Trial},
  author = {Thomas H. Brannagan and Markus Weiler and Márcia Waddington Cruz and Sami Khella and John L. Berk and Morie Gertz and Ahmad Masri and Mathew S. Maurer and Jonas Wixner and Jonatan Nåtman and T. Jesse Kwoh and Maksym Pola and Laura Obici},
  year = {2026},
  journal = {Journal of the Peripheral Nervous System},
  doi = {10.1111/jns.70167},
  url = {https://doi.org/10.1111/jns.70167}
}

RIS

TY  - JOUR
TI  - Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the
                    <scp>NEURO</scp>
                    ‐
                    <scp>TTRansform</scp>
                    Clinical Trial
AU  - Thomas H. Brannagan
AU  - Markus Weiler
AU  - Márcia Waddington Cruz
AU  - Sami Khella
AU  - John L. Berk
AU  - Morie Gertz
AU  - Ahmad Masri
AU  - Mathew S. Maurer
AU  - Jonas Wixner
AU  - Jonatan Nåtman
AU  - T. Jesse Kwoh
AU  - Maksym Pola
AU  - Laura Obici
PY  - 2026
JO  - Journal of the Peripheral Nervous System
DO  - 10.1111/jns.70167
UR  - https://doi.org/10.1111/jns.70167
ER  -

APA

Brannagan, T. H., Weiler, M., Cruz, M. W., Khella, S., Berk, J. L., Gertz, M., Masri, A., Maurer, M. S., Wixner, J., Nåtman, J., Kwoh, T. J., Pola, M., & Obici, L. (2026). Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the <scp>NEURO</scp> ‐ <scp>TTRansform</scp> Clinical Trial. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70167

Source records

crossref · retrieved 2026-09-25T02:49:01.902Z